Moreover, it was revealed that reducing HDGF expression might mitigate IGF2BP2/TUG1‐mediated CRC cisplatin resistance by inhibiting autophagy and suppressing the profiles of DDX5 and β‐catenin.100. The gene discussed is IGF2BP2; the disease is colorectal carcinoma.